IUPAC name
N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide
SMILES
CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
Compound class
Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dopamine Antagonists; Antidepressive Agents; Nervous System; Psycholeptics; Benzamides;
Therapeutic area
Sulpiride is indicated for the treatment of schizophrenia.
Common name
Sulpiride
IUPAC name
N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide
SMILES
CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
INCHI
InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)
FORMULA
C15H23N3O4S
Common name
Sulpiride
IUPAC name
N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide
Molecular weight
341.426
clogP
0.354
clogS
-3.016
HBond Acceptor
5
HBond Donor
3
Total Polar Surface Area
101.73
Number of Rings
2
Rotatable Bond
6
| Drug ID | Common name | Structure CAS | SMILE | Frequency |
|---|---|---|---|---|
| FDBF00003 | formamide |
|
C(=O)N | 0.1240 |
| FDBF00005 | benzene |
|
c1ccccc1 | 0.2824 |
| FDBF00690 | pyrrolidine |
|
N1CCCC1 | 0.0072 |
| FDBF00847 | 1-ethylpyrrolidine |
|
CCN1CCCC1 | 0.0027 |
| FDBF00855 | (2R)-2-methylpyrrolidine |
|
CC1NCCC1 | 0.0014 |
| FDBF00857 | N-[[(2S)-pyrrolidin-2-yl]methyl]formamide |
|
C(NC=O)C1NCCC1 | 0.0010 |
| FDBF00858 | N-methylbenzamide |
|
CNC(=O)c1ccccc1 | 0.0031 |
| FDBF00859 | 2-methoxybenzamide |
|
c1(ccccc1OC)C(=O)N | 0.0014 |
| FDBF00860 | 2-methoxy-N-methyl-benzamide |
|
CNC(=O)c1ccccc1OC | 0.0007 |
| FDBF00861 | N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]formamide |
|
C(C)N1C(CCC1)CNC=O | 0.0007 |
14 ,
2
